P. Gerry Fegan

1.0k total citations · 1 hit paper
47 papers, 610 citations indexed

About

P. Gerry Fegan is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, P. Gerry Fegan has authored 47 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Cardiology and Cardiovascular Medicine and 8 papers in Surgery. Recurrent topics in P. Gerry Fegan's work include Diabetes Treatment and Management (20 papers), Diabetes Management and Research (14 papers) and Cardiovascular Function and Risk Factors (8 papers). P. Gerry Fegan is often cited by papers focused on Diabetes Treatment and Management (20 papers), Diabetes Management and Research (14 papers) and Cardiovascular Function and Risk Factors (8 papers). P. Gerry Fegan collaborates with scholars based in Australia, United Kingdom and Ireland. P. Gerry Fegan's co-authors include Bu B. Yeap, N. Lan, Girish Dwivedi, Angela C. Shore, Juliene Gonçalves Costa, Andrew Haynes, Louise H. Naylor, Gerald F. Watts, Daniel J. Green and Wendy A. Davis and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

P. Gerry Fegan

43 papers receiving 593 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?

2024 59 citations P. Gerry Fegan, Bu B. Yeap et al. profile →

Peers

Countries citing papers authored by P. Gerry Fegan

Since Specialization

Citations

This map shows the geographic impact of P. Gerry Fegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Gerry Fegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Gerry Fegan more than expected).

Fields of papers citing papers by P. Gerry Fegan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Gerry Fegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Gerry Fegan. The network helps show where P. Gerry Fegan may publish in the future.

Co-authorship network of co-authors of P. Gerry Fegan

This figure shows the co-authorship network connecting the top 25 collaborators of P. Gerry Fegan. A scholar is included among the top collaborators of P. Gerry Fegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Gerry Fegan. P. Gerry Fegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Prescribing of Renal and Cardiovascular Protective Drugs in Patients With Type 2 Diabetes and Chronic Kidney Disease: Analysis of Data From a Western Australian Quaternary Hospital 2025 ·Heart Lung and Circulation ·N. Lan, Bridget A. McFadden, Andrew D. Johnson, (unknown), P. Gerry Fegan, (unknown), (unknown), (unknown), (unknown), Girish Dwivedi	1
2	The combined impact of chronic kidney disease and ulcer severity on incident cardiovascular events in patients with diabetes‐related foot ulceration 2025 ·Physiological Reports ·N. Lan, (unknown), Ivana Ferreira, Jens Carsten Ritter, Laurens Manning, P. Gerry Fegan, Emma Hamilton, Girish Dwivedi	1
3	Early SGLT2 inhibitor use is associated with improved left atrial strain following acute coronary syndrome 2024 ·Acta cardiologica. Supplementum ·(unknown), (unknown), Abdul Rahman Ihdayhid, (unknown), (unknown), (unknown), Matthew Erickson, James M. Rankin, P. Gerry Fegan, Bu B. Yeap, Girish Dwivedi, N. Lan	0
4	Increased risk of major adverse cardiovascular events in patients with deep and infected diabetes-related foot ulcers 2024 ·Diabetologia ·N. Lan, (unknown), Ivana Ferreira, Jens Carsten Ritter, Laurens Manning, P. Gerry Fegan, Girish Dwivedi, Emma Hamilton	2
5	Western Australian medical students’ attitudes towards artificial intelligence in healthcare 2023 ·PLoS ONE ·Jonathon Stewart, Juan Lü, (unknown), Adrian Goudie, P. Gerry Fegan, Mohammed Bennamoun, Peter Sprivulis, Girish Dwivedi	40
6	Three Cases of Non-islet Cell Tumor Hypoglycemia Highlighting Efficacy of Glucocorticoid Treatment 2023 ·JCEM Case Reports ·(unknown), (unknown), P. Gerry Fegan, John P. Walsh	1
7	Comparison of coronary artery calcium score and cardiovascular risk-stratification by European Society of Cardiology Guidelines and Steno Type 1 Risk Engine in statin-naïve adults with type 1 diabetes 2023 ·Journal of Diabetes and its Complications ·(unknown), N. Lan, (unknown), Chris M. Wood, Ashu Gupta, Bu B. Yeap, P. Gerry Fegan	4
8	Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes 2023 ·Primary care diabetes ·N. Lan, (unknown), (unknown), Alicia J. Jenkins, P. Gerry Fegan	1
9	Characteristics and outcomes of patients with type 1 diabetes admitted with acute coronary syndromes 2022 ·Diabetes Research and Clinical Practice ·(unknown), N. Lan, Bu B. Yeap, Girish Dwivedi, P. Gerry Fegan, Abdul Rahman Ihdayhid	2
10	Managing inpatient hyperglycaemia and initiating sodium‐glucose cotransporter 2 inhibitor therapy in the setting of diabetes and acute coronary syndrome 2021 ·Internal Medicine Journal ·(unknown), N. Lan, (unknown), James M. Rankin, P. Gerry Fegan, Bu B. Yeap	2
11	Real-world barriers and safety of initiating sodium-glucose co-transporter 2 inhibitor treatment immediately following an acute cardiac event in people with diabetes 2021 ·Journal of Diabetes and its Complications ·(unknown), N. Lan, James M. Rankin, Robert Larbalestier, Bu B. Yeap, P. Gerry Fegan	3
12	Short-term outcomes following coronary artery bypass graft surgery in insulin treated and non-insulin treated diabetes: A tertiary hospital experience in Australia 2020 ·Diabetes & Metabolic Syndrome Clinical Research & Reviews ·N. Lan, Umar Ali, P. Gerry Fegan, Robert Larbalestier, (unknown), (unknown), Bu B. Yeap	3
13	Empagliflozin and left ventricular diastolic function following an acute coronary syndrome in patients with type 2 diabetes 2020 ·International journal of cardiac imaging ·N. Lan, Bu B. Yeap, P. Gerry Fegan, (unknown), James M. Rankin, Girish Dwivedi	24
14	Efficacy of Intermittently Scanned Continuous Glucose Monitoring in the Prevention of Recurrent Severe Hypoglycemia 2019 ·Diabetes Technology & Therapeutics ·Timothy M. E. Davis, (unknown), (unknown), P. Gerry Fegan, Wendy A. Davis	17
15	The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Left Ventricular Function: Current Evidence and Future Directions 2019 ·ESC Heart Failure ·N. Lan, P. Gerry Fegan, Bu B. Yeap, Girish Dwivedi	61
16	Higher Dihydrotestosterone Is Associated with the Incidence of Lung Cancer in Older Men 2017 ·Hormones and Cancer ·(unknown), Helman Alfonso, S. A. Paul Chubb, David J. Handelsman, P. Gerry Fegan, Graeme J. Hankey, Jonathan Golledge, Leon Flicker, Bu B. Yeap	19
17	Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma 2010 ·European Journal of Endocrinology ·Gregory S Y Ong, David Henley, David M. Hurley, (unknown), Phillip G. Claringbold, P. Gerry Fegan	41
18	Mirtazapine associated with profound hyponatremia: Two case reports 2008 ·The American journal of geriatric pharmacotherapy ·Chan Y. Cheah, (unknown), P. Gerry Fegan	10
19	Prevalence and associations of psychological distress in young adults with Type 1 diabetes 2008 ·Diabetic Medicine ·(unknown), P. Gerry Fegan, (unknown), (unknown), Bu B. Yeap	118
20	Microvascular endothelial function in subjects with Type 2 diabetes and the effect of lipid‐lowering therapy 2005 ·Diabetic Medicine ·P. Gerry Fegan, Angela C. Shore, D. Mawson, J. E. Tooke, (unknown)	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact